Pharmafile Logo
Pharmafocus logo
Advanced Search

breast cancer

Showing 15 posts of 170 posts found.

Herceptin

Herceptin faces UK competition within months

April 11, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Biocon, Herceptin, Hospira, Perjeta, breast cancer

Roche’s blockbuster breast cancer drug Herceptin may soon be under threat from copycat treatments after a court in the UK …

News
pfizer_floor_plate

Pfizer breast cancer drug combo aces trial

April 7, 2014
Femera, Pfizer, breast cancer, oncology, palbociclib

News
servier image

Servier signs cancer partnership

January 29, 2014
Research and Development, Sales and Marketing AbbVie, Servier, breast cancer, curie

Servier has extended by three years its deal with leading research group Curie-Cancer to identify therapeutic targets for treating triple-negative …

News
Herceptin

Roche’s new Herceptin jab approved by NHS

September 25, 2013
Sales and Marketing Herceptin, Kadcyla, Roche, breast cancer

News
bowel_cancer_screening

FDA approves first generic Xeloda

September 17, 2013
Sales and Marketing FDA, Roche, Teva, Xeolda, breast cancer, colorectal cancer

News
herceptin image

EU green light for ‘new’ Herceptin

September 3, 2013
Sales and Marketing EU, Herceptin, Roche, breast cancer

 Roche has ticked another approval off Herceptin’s list with the news that the European Commission is allowing a new form …

News

Breast cancer patients benefit from blogging

September 2, 2013
Medical Communications blogging, breast cancer

Breast cancer patients who discuss their personal experiences with the disease online can help both the authors and their audience. …

News

Afinitor too costly for NICE despite price cut

August 29, 2013
Sales and Marketing Afinitor, HER2 negative, NICE, Novartis, breast cancer

News
Tyvber image

GSK and Roche get EU breast cancer indication

August 15, 2013
Sales and Marketing GSK, Herceptin, Roche, Tyverb, Xeloda, breast cancer

The European Commission has granted a new indication for the use of GSK’s breast cancer drug Tyverb in combination with …

News
fda image

FDA gives Perjeta priority

July 3, 2013
Sales and Marketing FDA, Perjeta, Roche, breast cancer

The FDA has granted priority review status to an application for Roche’s Perjeta to be used before surgery in HER2-positive …

News
Afinitor image

Afinitor’s new UK indication launched

September 20, 2012
Sales and Marketing Afinitor, CHMP, Novartis, breast cancer

Novartis’ cancer drug Afinitor has been made available in the UK for patients with the most common form of advanced …

News
Avastin image

Another NICE no for Avastin in breast cancer

August 22, 2012
Sales and Marketing NICE, avastin, breast cancer, rejection

Roche’s Avastin has been rejected once again for use in breast cancer patients.  NICE has now issued final guidance saying …

News
Roche image

Roche winning on Perjeta supply, but running short of Boniva

August 20, 2012
Manufacturing and Production, Sales and Marketing Boniva, Perjeta, Roche, breast cancer

Roche is getting production for its new breast cancer drug Perjeta back on track after some initial teething troubles, but …

News
Avastin pack shot

NICE no for Avastin in breast cancer

July 6, 2012
Sales and Marketing NICE, Roche, avastin, breast cancer, rejection

NICE has decided once again not to recommend Roche’s Avastin on the NHS for the first line treatment of metastatic …

News
Roche image

Roche’s Perjeta increases survival

June 27, 2012
Research and Development, Sales and Marketing EMA, FDA, Herceptin, Perjeta, Roche, breast cancer

Roche’s new drug Perjeta has scored another trial success by increasing overall survival in certain breast cancer patients. The new …

News

Latest content

Merck shares data from phase 3 trial of Keytruda for gastric cancers

May 2, 2024

Verona Pharma to share phase 3 COPD trial data at ATS 2024

May 2, 2024

Beckman Coulter Life Sciences and Watchmaker Genomics enter collaboration

May 1, 2024

Veru announces first patients enrolled in phase 2b trial for weight loss treatment

May 1, 2024

Bayer and Evotec to collaborate on precision cardiology

April 30, 2024